The object of the study will be children and adolescents from 6 to 15 years old, living in the city of Tashkent and in the Tashkent region. We will study patients with various clinical forms of chronic gastroduodenal pathology (CGDP). The effect of enteral oxygen therapy in the recovery of patients with CGDP due to the positive effect of the active form of oxygen on the hematological system and on the regenerative processes in the gastrointestinal tract will be studied. At the same time, the effect of enteral oxygen therapy on enhancing the effectiveness of eradication therapy during the treatment of carrier Helicobacter pylori due to the neutralization of the products of urea hydrolysis around bacteria under the action of reactive oxygen species will be studied.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Initial clinical examination of children and adolescents at risk of CGDP.
Timeframe: 2 weeks
Identification of Helicobacter pylori infection.
Timeframe: 2 weeks
Esofibrogastroduodenoscopy at the start of the study
Timeframe: 2 weeks
Treatment of identified patients.
Timeframe: 6 weeks
Rehabilitation of patients using enteral oxygen therapy.
Timeframe: 6 weeks
Esofibrogastroduodenoscopy after rehabilitation.
Timeframe: 2 weeks